Pentylenetetrazol in the treatment of geriatric patients with disturbed memory function.
D000368:Aged; D002245:Carbon Dioxide / Q000494:pharmacology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002986:Clinical Trials as Topic; D003243:Consciousness / Q000187:drug effects; D003704:Dementia; D005260:Female; D006801:Humans; D007361:Intelligence Tests; D008297:Male; D008568:Memory / Q000187:drug effects*; D008569:Memory Disorders / Q000188:drug therapy*; D019965:Neurocognitive Disorders; D010433:Pentylenetetrazole / Q000627:therapeutic use*; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia
D010919:Placebos; D002245:Carbon Dioxide; D010433:Pentylenetetrazole